Hydrofarm Holdings Group, Inc. filed a Form 8-K on November 12, 2026, announcing that it received a letter dated November 9, 2026 from Nasdaq's Office of General Counsel confirming the company had regained compliance with Nasdaq's minimum stockholders' equity listing requirement.

Key Highlights

  • Compliance restored: Nasdaq's Office of General Counsel confirmed on November 9, 2026 that Hydrofarm has regained compliance with the $2.5 million minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1).
  • Mandatory Panel Monitor: The company remains subject to a Mandatory Panel Monitor, as defined in Nasdaq Listing Rule 5815(d)(4)(B), for one year through November 9, 2027.
  • Delist risk if violated: If the company fails to satisfy the Equity Rule during the monitor period, it will not be permitted to submit a compliance plan and would instead receive a delist notice, which it could appeal to a Nasdaq Hearings Panel.
  • Triggering events: The company's noncompliance was first flagged by Nasdaq in a letter received April 1, 2026, and a registered direct offering and concurrent private placement were completed on October 27, 2026, along with termination of its senior secured term loan.
  • Additional listing risk noted: The company disclosed it is monitoring compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), among other continued listing standards.

Hydrofarm's Path Back to Nasdaq Equity Compliance After April 2026 Deficiency Notice

According to the filing, Hydrofarm Holdings Group, Inc. (NASDAQ:HYFM) first received a deficiency notice from Nasdaq's Listing Qualifications Department on April 1, 2026, stating the company did not meet the $2.5 million minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market under Listing Rule 5550(b)(1). The company subsequently completed a registered direct offering and concurrent private placement of its securities on October 27, 2026, and simultaneously terminated its senior secured term loan under its Credit and Guaranty Agreement dated October 25, 2021.

On November 12, 2026, the company issued a press release reporting that on November 9, 2026, it received confirmation from Nasdaq's Office of General Counsel that it had regained compliance with the Equity Rule. However, the filing states the company remains subject to a Mandatory Panel Monitor for one year through November 9, 2027. During that period, if the company again fails to satisfy the Equity Rule, it will not be given the opportunity to submit a compliance plan to Nasdaq staff; instead, a delist notice would be issued, which the company could then appeal to a Nasdaq Hearings Panel. The filing notes that a hearing request would stay any further delisting action at least until such hearing is held and any extension granted by the Panel has expired.

The company disclosed it "intends to monitor its stockholders' equity and its compliance with the other Nasdaq continued listing requirements, including the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), and to take such actions as may be necessary to regain or maintain compliance." The filing adds, however, that "there can be no assurance that the Company will be able to maintain compliance with the Equity Rule or regain or maintain compliance with any other Nasdaq Listing Rule." Statements regarding future compliance are described by the company as forward-looking and subject to risks and uncertainties.

What Was Disclosed

Hydrofarm filed an 8-K on November 12, 2026 disclosing that Nasdaq confirmed on November 9, 2026 the company had regained compliance with the minimum stockholders' equity rule, while also noting the company is now subject to a one-year Mandatory Panel Monitor through November 9, 2027.